HUP0003681A1 - K-vitamin-függő egyedi faktorokat tartalmazó gyógyszerkészítmény - Google Patents

K-vitamin-függő egyedi faktorokat tartalmazó gyógyszerkészítmény

Info

Publication number
HUP0003681A1
HUP0003681A1 HU0003681A HUP0003681A HUP0003681A1 HU P0003681 A1 HUP0003681 A1 HU P0003681A1 HU 0003681 A HU0003681 A HU 0003681A HU P0003681 A HUP0003681 A HU P0003681A HU P0003681 A1 HUP0003681 A1 HU P0003681A1
Authority
HU
Hungary
Prior art keywords
containing various
substance containing
pharmaceutical substance
various vitamin
dependent factors
Prior art date
Application number
HU0003681A
Other languages
English (en)
Hungarian (hu)
Inventor
Yendra Linnau
Hans-Peter Schwarz
Peter Turecek
Original Assignee
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Aktiengesellschaft filed Critical Baxter Aktiengesellschaft
Publication of HUP0003681A1 publication Critical patent/HUP0003681A1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HU0003681A 1997-09-19 1998-09-17 K-vitamin-függő egyedi faktorokat tartalmazó gyógyszerkészítmény HUP0003681A1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Publications (1)

Publication Number Publication Date
HUP0003681A1 true HUP0003681A1 (hu) 2001-02-28

Family

ID=3516739

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003681A HUP0003681A1 (hu) 1997-09-19 1998-09-17 K-vitamin-függő egyedi faktorokat tartalmazó gyógyszerkészítmény

Country Status (10)

Country Link
EP (1) EP1015020A1 (fr)
JP (1) JP2001517636A (fr)
AT (1) AT409334B (fr)
AU (1) AU743102B2 (fr)
BR (1) BR9812222A (fr)
CA (1) CA2304396A1 (fr)
HU (1) HUP0003681A1 (fr)
NO (1) NO20001415L (fr)
SK (1) SK4022000A3 (fr)
WO (1) WO1999015196A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002351756A1 (en) 2001-12-21 2003-07-15 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
AU2003213146A1 (en) * 2002-03-08 2003-09-22 Eli Lilly And Company Activated protein c formulations
PT1517698E (pt) 2002-06-21 2014-11-19 Novo Nordisk Healthcare Ag Composições sólidas estabilizadas de polipéptidos do fator viia
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
KR20060015574A (ko) 2003-05-23 2006-02-17 노보 노르디스크 헬스 케어 악티엔게젤샤프트 용액 중 단백질 안정화
WO2004112828A1 (fr) 2003-06-25 2004-12-29 Novo Nordisk Health Care Ag Composition liquide de polypeptides du facteur vii
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
RU2373953C2 (ru) 2003-12-19 2009-11-27 Ново Нордиск Хелс Кеа Аг Стабилизированная композиция, содержащая полипептид фактора vii
US20080260858A1 (en) * 2005-02-16 2008-10-23 The Board Of Trustees Of The University Of Illnois Universal Procoagulant
JP2008531692A (ja) 2005-03-04 2008-08-14 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 凝固及び線維素溶解カスケードのモジュレーター
WO2009046194A2 (fr) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Produit d'étanchéité de fibrine
WO2009061697A1 (fr) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Antagoniste d'anticoagulant et procoagulant anti-hémophilique
CN104193798A (zh) 2009-12-18 2014-12-10 Csl有限公司 纯化多肽的方法
CA2812888A1 (fr) * 2010-10-06 2012-04-12 Medimmune Limited Facteur ii et fibrinogene pour le traitement de troubles hemostatiques
SG10201912497WA (en) * 2017-02-09 2020-02-27 Csl Behring Gmbh A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders

Also Published As

Publication number Publication date
AU9244998A (en) 1999-04-12
CA2304396A1 (fr) 1999-04-01
EP1015020A1 (fr) 2000-07-05
AT409334B (de) 2002-07-25
BR9812222A (pt) 2000-07-18
JP2001517636A (ja) 2001-10-09
AU743102B2 (en) 2002-01-17
NO20001415L (no) 2000-05-19
WO1999015196A1 (fr) 1999-04-01
SK4022000A3 (en) 2000-09-12
NO20001415D0 (no) 2000-03-17
ATA159197A (de) 2001-12-15

Similar Documents

Publication Publication Date Title
HUP0003681A1 (hu) K-vitamin-függő egyedi faktorokat tartalmazó gyógyszerkészítmény
IL147037A0 (en) Peptide acceptor ligation methods
SE9704546D0 (sv) Novel compounds
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
ES2098140T3 (es) Liosferas que contienen gonadotropina.
AU2003243096A1 (en) NOVEL PURINE- OR PYRROLOL(2,3-d)PYRIMIDINE-2-CARBONITILES FOR TREATING DISEASES ASSOCIATED WITH CYSTEINE PROTEASE ACTIVITY
EP1153548B8 (fr) Produit alimentaire contenant de la vitamine k2
IT1302347B1 (it) Procedimento per la produzione diretta di perossido di idrogeno.
DE69905170D1 (en) Thiazolopyrimidinderivate
GB0031527D0 (en) New use
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
YU5800A (sh) Univerzalno primenljiva krvna plazma
AR029590A1 (es) Antibacterianos
FI963251L (fi) Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita
ZA983792B (en) New cysteine derivatives, processes for their production, and pharmaceuticals containing them.
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
AU1932997A (en) Dosage forms and uses
ID27733A (id) Metoksiminofenilasetamida
CA98653S (en) Shinguard
AU2002330445A1 (en) Carrier for bottles and the like
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
ATE331733T1 (de) Metallhaltige ribonukleotidpolypeptide
ATE227997T1 (de) Pharmazeutische zusammensetzung zur nasalen verabreichung von thiocolchicosid
EP1306366A3 (fr) Dérivés de dibenzosubérone